Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Share Option Plan Awards

9 Jul 2020 07:00

RNS Number : 4617S
First Derivatives PLC
09 July 2020
 

9 July 2020

 

First Derivatives plc

("FD" or the "Group")

 

Share Option Plan awards

 

FD (AIM: FDP.L, Euronext Growth: FDP.I) announces that on 8 July 2020 Seamus Keating, CEO, was granted options over 250,000 ordinary shares of 0.5p each ("Ordinary shares") and Graham Ferguson, CFO, was granted options over 75,000 Ordinary shares under the Group's Share Option Plan.

 

In each case, the option exercise price is 2,595p and the options will vest after four years on the achievement of challenging total shareholder return (TSR) and earnings per share (EPS) growth targets. Both TSR and EPS targets are independent of each other and are weighted 50:50 for any award vesting.

 

For the TSR portion, 50% will vest for threshold performance, which is defined as 50% TSR over the four-year performance period. This translates to a CAGR of nearly 11%. Vesting then increases on a straight-line basis to full vesting for TSR of 100% (i.e., doubling of value over the four-year performance period, or a CAGR of nearly 19%).

 

For the EPS growth portion, 50% will vest for threshold performance, which is defined as 75% EPS growth over the four-year performance period, or a CAGR of 15%. Vesting will increase on a straight-line basis to full vesting for EPS growth of 100%.

 

The option grants are in line with the Group's remuneration policy and are subject to typical holding, malus and clawback provisions.

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

 

Name

 

 

 Seamus Keating

2.

Reason for the notification

a)

Position / status

 Chief Executive Officer

 

b)

Initial notification / amendment

 Initial Notification

3.

Details of the Issuer

a)

Name

First Derivatives plc

b)

LEI

213800MKQAJ5R7WIU633

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of £0.005

 ISIN: GB0031477770 

b)

Nature of the transaction

Award of share options

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

250,000

d)

Aggregated information

 - Aggregated volume

 - Price

N/a - single transaction

e)

Date of the transaction

8 July 2020

f)

Place of the transaction

Outside a trading venue

 

 

2.

Details of PDMR / person closely associated with them ("PCA")

a)

 

Name

 

 

 Graham Ferguson

2.

Reason for the notification

a)

Position / status

 Chief Financial Officer

 

b)

Initial notification / amendment

 Initial Notification

3.

Details of the Issuer

a)

Name

First Derivatives plc

b)

LEI

213800MKQAJ5R7WIU633

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of £0.005

 ISIN: GB0031477770 

b)

Nature of the transaction

Award of share options

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

75,000

d)

Aggregated information

 - Aggregated volume

 - Price

N/a - single transaction

e)

Date of the transaction

8 July 2020

f)

Place of the transaction

Outside a trading venue

 

 

 

Enquiries

For further information please contact:

First Derivatives plc

Seamus Keating, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc (Nominated Adviser and Broker)

Andrew Pinder

Carlton Nelson

Sebastian Lawrence

+44 (0) 20 7597 5970

 

 

Goodbody (Euronext Growth Adviser and Broker)

David Kearney

Don Harrington

Finbarr Griffin

+353 (0)1 667 0420

 

 

FTI Consulting

Matt Dixon

Dwight Burden

Darius Alexander

 

+44 (0) 20 3727 1000

About FD

FD is a global technology provider with more than 20 years of experience working with some of the world's largest finance, technology, automotive, manufacturing and energy institutions. The Group's Kx technology, incorporating the kdb+ time-series database, is a leader in high-performance, in-memory computing, streaming analytics and operational intelligence. Kx delivers the best possible performance and flexibility for high-volume, data-intensive analytics and applications across multiple industries. FD operates from 15 offices across Europe, North America and Asia Pacific, including its headquarters in Newry, and employs more than 2,400 people worldwide.

 

For further information, please visit www.firstderivatives.com and www.kx.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUWSWRROUBRAR
Date   Source Headline
6th Jun 20177:00 amRNSEnterprise Securities Market Notice
2nd Jun 20179:56 amRNSAnnual Report 2016/17 and AGM Notice
30th May 20175:13 pmRNSDirector/PDMR Shareholding
30th May 20175:12 pmRNSDirector/PDMR Shareholding
30th May 20172:06 pmRNSIssue of Equity from exercise of Share Options
16th May 20177:00 amRNSFinal Results
15th May 20175:09 pmRNSAppointment and Directorate Change
24th Apr 20177:00 amRNSTrading Update and Notice of Results
3rd Apr 201710:28 amRNSTotal Voting Rights
20th Mar 20177:00 amRNSEnterprise Securities Market Notice
14th Mar 20174:39 pmRNSIssue of Equity
14th Mar 20177:00 amRNSCollaboration Agreement with Airbus
2nd Mar 20177:00 amRNSContract Win
28th Feb 201710:09 amRNSTotal Voting Rights
7th Feb 20177:00 amRNSEnterprise Securities Market Notice
1st Feb 20173:54 pmRNSIssue of Equity
30th Dec 201610:57 amRNSTotal Voting Rights
23rd Dec 20167:00 amRNSEnterprise Securities Market Notice
19th Dec 20164:06 pmRNSIssue of Equity
7th Dec 20161:26 pmRNSHolding(s) in Company
7th Dec 20167:00 amRNSEnterprise Securities Market Notice
1st Dec 20164:52 pmRNSIssue of Equity from exercise of Share Options
30th Nov 201612:21 pmRNSTotal Voting Rights
8th Nov 20167:00 amRNSEntry into Retail Analytics market
8th Nov 20167:00 amRNSEnterprise Securities Market Notice
3rd Nov 20164:21 pmRNSDirector/PDMR Shareholding
3rd Nov 20164:20 pmRNSDirector/PDMR Shareholding
3rd Nov 20164:19 pmRNSDirector/PDMR Shareholding
1st Nov 20166:13 pmRNSIssue of Equity
1st Nov 20167:00 amRNSHalf Yearly Report
19th Oct 20167:00 amRNSNotice of Interim Results
30th Sep 20169:53 amRNSTotal Voting Rights
14th Sep 20167:00 amRNSEnterprise Securities Market Notice
7th Sep 20162:15 pmRNSIssue of Equity from exercise of Share Options
29th Jul 20161:29 pmRNSTotal Voting Rights
20th Jul 20164:59 pmRNSDirector Shareholding - AMENDMENT
19th Jul 20165:03 pmRNSDirector Shareholding
12th Jul 20167:00 amRNSDirector/PDMR Shareholding
30th Jun 20168:05 amRNSTotal Voting Rights
23rd Jun 20162:06 pmRNSResult of AGM
15th Jun 20167:00 amRNSDirector/PDMR Shareholding
6th Jun 201612:00 pmRNSIssue of Equity from exercise of Share Options
3rd Jun 20163:45 pmRNSAnnual Report 2015/16 and AGM Notice
19th May 20165:11 pmRNSHolding(s) in Company
17th May 20167:00 amRNSFinal Results
13th May 20164:38 pmRNSDirectorate Change
27th Apr 20167:00 amRNSStrategic Partnership with Thomson Reuters
26th Apr 20167:00 amRNSNotice of Results
4th Apr 20167:00 amRNSTrading Update
31st Mar 20164:44 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.